Navigation Links
April 2009 Declared National Safe Handling Awareness Month
Date:2/24/2009

National Campaign Aims to Protect Healthcare Workers from Hazardous Drug Exposure

COLUMBUS, Ohio, Feb. 24 /PRNewswire/ -- In an act to further education surrounding the safe handling of hazardous drugs in the healthcare setting, April 2009 has been declared the first-ever National Safe Handling Awareness Month with Monday, April 20, 2009 being declared the first-ever National Safe Handling Awareness Day.

The proclamation of National Safe Handling Awareness Month follows the need for increased safe handling cognizance given the known risks associated with exposure to hazardous drugs (such as chemotherapy agents). According to an alert published by the National Institute for Occupational Safety and Health (NIOSH), "working with or near hazardous drugs in healthcare settings may cause skin rashes, infertility, miscarriage, birth defects and possibly leukemia or other cancers.(1) Further evidence to support the need to take action in this area may be found below.

In recognition of National Safe Handling Awareness Month, a variety of regional and national continuing education (CE) activities will be scheduled throughout April. The headline event, a complimentary, nationwide CE webcast, will take place on April 20th from 1:00-2:00pm EST. The event will be followed by a live "Ask the Experts" session featuring today's industry thought leaders:

    Keynote speakers:
    Byron Peters, RPh
    Director of Pharmacy
    Siteman Cancer Center, Washington University School of Medicine, St.
    Louis, MO

    MiKaela Olsen, RN, MS, OCN
    Oncology and Hematology Clinical Nurse Specialist
    Johns Hopkins Hospital, Baltimore, MD

    Guest Speaker:
    James Jorgenson, RPh, MS, FASHP
    Executive Director, Pharmacy Services
    Clarian Health Partners, Methodist Hospital, Indianapolis, IN

This initiative is supported by an unrestricted educational gra
'/>"/>

SOURCE Carmel Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Blue Cross and Blue Shield Companies to Host Second Annual National Walk @ Lunch Day(SM) on April 30, 2008
2. Experimental Biology 2008 Todays Research: Tomorrows Health, April 5-9
3. Parental Alienation Awareness Organization Begins Preparations for Parental Alienation Awareness Day - April 25th
4. Sundance Channel to Premiere Documentary Autism Every Day on World Autism Awareness Day, April 2nd at 8:00pm et/pt
5. Dr. Oliver Sacks, NYT Bestselling Author, to Inspire and Marc Black, Award-winning Musician, to Perform at National Aphasia Association Benefit on April 1, NYC
6. TRIZCON2008 at Kent State, April 13-15
7. Hazelden President and CEO Ellen Breyer to Step Down April 4
8. Media Invited to Attend International Society for Heart & Lung Transplantation Meeting in Boston, April 9-12
9. News and features abound at ACS National Meeting in New Orleans, April 6-10
10. COMEDY CENTRAL(R) Announces Live On-Air Charity Special Night Of Too Many Stars: An Overbooked Benefit For Autism Education Hosted by Jon Stewart on Sunday April 13, at 8 p.m. ET
11. 2008 Building Biology(R) Conference, April 19th & 20th, Hotel Radisson at Opryland, Nashville, Tennessee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 02, 2015 The National Association ... as a 2015-2016 inductee into its VIP Professional ... this prestigious distinction for leadership in safety, environment, health ... organization exclusively for professional women, boasting more than 700,000 ... pleased to present Lourinda with this important honor,” said ...
(Date:6/1/2015)... (PRWEB) June 02, 2015 The ... Lenita F. Cornett, DSL, LSSBB (C), First Sergeant A ... VIP Woman of the Year Circle. She is recognized ... NAPW is the nation's leading networking organization exclusively for ... 200 operating Local Chapters. , “I'm pleased to recognize ...
(Date:6/1/2015)... York, New York (PRWEB) June 01, 2015 ... ( http://www.testosteronelawsuithub.com/ ) has amended the Case Management ... Inc.’s AndroGel testosterone gel. The Amended Order which ... of Illinois on May 29, 2015, directs the parties ... Court by August 10, 2015 that outlines parameters and ...
(Date:6/1/2015)... D.C. (PRWEB) June 01, 2015 Linda Kincaid, ... and had an irregular heartbeat. At first she thought it ... found out it was much more than that. After going ... disease. Linda admitted she felt afraid about what might happen ... five million Americans are diagnosed with valve disease each year. ...
(Date:6/1/2015)... 2015 EBSCO Health , a ... DynaMed Plus™ , a cross-platform evidence-based clinical decision ... provides clinicians with the ideal blend of evidence and ... , DynaMed Plus is a significant enhancement over ... most frequently updated evidence-based content. DynaMed Plus content is ...
Breaking Medicine News(10 mins):Health News:National Association of Professional Women Inducts Lourinda Willey, Owner and Principal of Lourinda R. Willey LLC, Into its VIP Professional Woman of the Year Circle 2Health News:National Association of Professional Women Inducts Lenita F. Cornett, First Sergeant of the US Military, Into its VIP Professional Woman of the Year Circle 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 2Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 3Health News:Testosterone Lawsuit News: Federal Court Amends Order Governing AndroGel Bellwether Trial Selection 4Health News:A New Online Resource for Those Living with Heart Valve Disease 2Health News:A New Online Resource for Those Living with Heart Valve Disease 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 2Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 3Health News:EBSCO Health’s New DynaMed Plus™ Delivers Trusted, Evidence-Based Content to Physicians on Any Platform 4
... fruit flies get high cholesterol and become obese? The same ... too rich in fats. More importantly, according to two ... fruit flies use the same molecular mechanisms as humans to ... of stored fat that contributes to obesity. The findings mean ...
... , ARLINGTON, Va., Dec. 2 ... life that give us meaning, joy and peace, the LIFE ... using the popular photo-sharing Web site flickr.com. The winning photos ... Foundation,s Web site at www.lifehappens.org/wondersphotos . , Contestants ...
... Dec. 2 Aegis Health Group, the nation,s leading ... chief development officer. As a member of Aegis, executive ... the sales and marketing staff as they focus on ... and physician relationships. , To this newly created position, ...
... point to death from TB, not Addison,s, researcher says ... Pride and Prejudice and Emma ... has long been believed, says one British scholar. , Since ... many historians and other experts have believed the cause was ...
... , LONDON, Dec. 2 ... therapies to treat lifestyle disorders. In the near future, the ... therapies and novel drugs to treat such conditions and reduce ... New analysis from Frost & Sullivan ( http://www.pharma.frost.com ), ...
... ... Links Medical Products Inc., an industry leader in healthcare products for hospitals ... Irvine Spectrum. The new facility is located at 9247 Research Drive, Irvine, ... Spectrum plus an assembly and distribution operation in Indio, California. This most ...
Cached Medicine News:Health News:Latest epidemic? High cholesterol, obesity in fruit flies 2Health News:Latest epidemic? High cholesterol, obesity in fruit flies 3Health News:Wonders of Life Photo Contest Winners Announced 2Health News:Wonders of Life Photo Contest Winners Announced 3Health News:Aegis Health Group Hires Pearson Talbert as Chief Development Officer 2Health News:New Light on Jane Austen's Final Chapter 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 2Health News:Development of Newer Therapies to Treat Lifestyle Disorders and Reduce the Risk of Co-morbidities is Key to the Expansion of the European Lifestyle Disorders Therapeutics Market, Says Frost & Sullivan 3Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3
(Date:6/1/2015)... -- Lee Tran & Liang LLP (LTL), ... and Yik Yak co-founder disputes, announced today ... most promising biotechnology start-ups in the country, Resilience Therapeutics, ... Sabados .  LTL represents Veronica Sara Weiner , ... fellow scientist at the Massachusetts Institute of Technology.      ...
(Date:6/1/2015)... 2015   Regulus Therapeutics Inc . ( ... discovery and development of innovative medicines targeting microRNAs, ... Ph.D. has resigned as President and Chief Executive ... of Directors, effective today, to pursue investment opportunities ... previously served as Chief Medical Officer of Regulus, ...
(Date:6/1/2015)... Pharmaceuticals, Inc. (Nasdaq: MACK ) today announced data for ... a Phase 1 investigator-sponsored study at the University of ... at the 2015 American Society of Clinical Oncology (ASCO) ... Results from this study show a tolerable safety profile ... intravenously.  Based in part on the data ...
Breaking Medicine Technology:Lee Tran & Liang LLP Files Co-Founder Lawsuit against Leading Biotech Start-up Resilience 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 2Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 3Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 4Merrimack Pharmaceuticals Announces Data from an Investigator-Sponsored Phase 1 Study Showing Acceptable Safety Profile for MM-398 in High-Grade Glioma 5
... DALLAS, Oct. 15 /PRNewswire-FirstCall/ -- ACCESS ... provided an update on its European commercial launch of ... debilitating side effect of radiation treatment and chemotherapy. ... five European countries, having been granted the CE mak ...
... Pharmaceuticals, Inc. announced today that new data confirm that ... of fat absorption in children aged 7-11 years who ... (CF). EPI is a condition resulting from a deficiency ... are necessary to digest nutrients in food. CREON® has ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 2CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 3CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 5CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 6
Ruschelit® PVC. Magill tip-nasoral. Black positioning ring. High volume/low pressure cuff. X-ray opaque line. Graduated. Single use....
Ruschelit® PVC. Siliconized. Stainless steel spiral reinforced. High volume/low pressure cuff.Connector is permanently fixed into the tube. X-ray opaque. Graduated. Single use. Sterile...
Tube for Right Bronchus - Ruschelit™ PVC. Color coded for easy identification of ports, balloons and 15mm connectors. High volume/low pressure cuffs. With Carina hook. X-ray opaque line. Gradua...
Laser resistant tubes for use with CO2 and KTP Lasers., ,Designed for airway management during laser surgery of the larynx or other areas in close proximity to the trachea....
Medicine Products: